@the_news_21
Oxford-AstraZeneca coronavirus vaccine ‘Covishield’ has been given permission for emergency use in India by an expert panel formed by the central government, as per reports now application will be sent to Drugs Controller General of India (DCGI) V.G. Somani for final approval.
The expert panel had convened the key meeting today to take a call on the pleas sent in by SII and indigenous pharmaceutical firm Bharat Biotech, for its ‘Covaxin’ coronavirus candidate.
A dry run for vaccination is scheduled in all the states tomorrow.
Health Minister Harsh Vardhan will monitor and analyse the dry run in the national capital. “The preparations are like general elections, where even the booth-level preparations are made. The purpose of the dry run is to be ready for the actual rollout… Potential recipients of vaccine will be informed via SMS. Frontline workers are the priority. After inoculation, digital certificate will also be provided,” the health Minister said.
The expert panel recommending the affordable Oxford vaccine to the drugs regulator is a big development for India in the fight against the pandemic on the first day of the new year, as the country has the second-biggest number of COVID-19 infections after the US. The government plans to vaccinate 30 crore people in India in six to eight months.
